The leading independent clinical services provider

The economic burden of Chronic Obstructive Pulmonary Disease (COPD) is significant and increasing. It is the second most common cause of emergency admissions to hospital, and one of the costliest inpatient conditions treated by the NHS. An average general practice in the UK caring for about 7,000 people will have up to 200 people with COPD on its practice list.

Attend2: COPD is a clinical platform developed by Interface Clinical Services that can be used to support the management of patients with COPD. It helps support the practice in achieving QOF indicators by highlighting patients missing key records such as FEV1, MRC score and annual review.


Attend2: COPD is underpinned by national and international guidelines (including the GOLD report and NICE NG115) and is used to identify patients who may benefit from a review of their current management strategy.

Attend2: COPD performs a comprehensive stratification of COPD patients across a healthcare organisation’s patient database, taking into account a patient’s current level of symptoms and treatment, concordance and co-morbidities along with other risk factors such as smoking status. Stratifying patients according to the level of clinical need allows practices to more effectively plan and prioritise their workload.

Details of reviews and interventions can be logged against individual patients within the Attend2: COPD platform. Dynamic reporting provides a detailed before and after analysis of practice COPD management. This can be used as part of the clinical audit cycle to evaluate change and demonstrate quality improvement in the care of patients with COPD.